Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marco Silvestri
Observed names:
M. Silvestri,
Silvestri, Marco
Institutions:
Fondazione IRCCS Istituto Nazionale dei Tumori,
Politecnico di Milano
Observed institutions:
Fondazione IRCCS Istituto Nazionale dei Tumori,
IRCCS Humanitas Research Hospital,
University of Brescia,
Politecnico di Milano
ORCID:
0000-0001-8283-9130
Observed ORCID:
0000-0001-8283-9130
OpenAlex ID:
A5064488646
Metabolic Footprints and Molecular Subtypes in Breast Cancer
2017
·
Vera Cappelletti
, Egidio Iorio
, et al.
·
Disease Markers
·
108
PDF
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy
2021
·
E. Ortolan
, V. Appierto
, et al.
·
ESMO Open
·
62
PDF
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy
2020
·
Serena Di Cosimo
, Valentina Appierto
, et al.
·
International Journal of Molecular Sciences
·
50
PDF
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells
2019
·
Carolina Reduzzi
, Marta Vismara
, et al.
·
Seminars in Cancer Biology
·
49
PDF
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression
2020
·
Vera Cappelletti
, Elena Verzoni
, et al.
·
International Journal of Molecular Sciences
·
48
PDF
Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk
2022
·
Elena De Mattia
, Marco Silvestri
, et al.
·
Biomedicine & Pharmacotherapy
·
41
PDF
A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
2019
·
Carolina Reduzzi
, Marta Vismara
, et al.
·
International Journal of Cancer
·
29
PDF
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma
2022
·
Marta Vismara
, Carolina Reduzzi
, et al.
·
Clinical Chemistry
·
27
PDF
Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenues
2024
·
A. Busico
, P. Gasparini
, et al.
·
Scientific Reports
·
25
Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy
2019
·
Serena Di Cosimo
, Valentina Appierto
, et al.
·
Cancers
·
22
PDF
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer
2022
·
Marco Silvestri
, Matteo Dugo
, et al.
·
Scientific Reports
·
21
PDF
The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity
2023
·
Elena De Mattia
, Jerry Polesel
, et al.
·
Human Genomics
·
15
PDF
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients
2020
·
Chiara Romani
, Valentina Zizioli
, et al.
·
Frontiers in Oncology
·
14
PDF
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO
2024
·
S. Pizzamiglio
, C. M. Ciniselli
, et al.
·
Breast Cancer Research and Treatment
·
12
PDF
Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients
2021
·
Marco Silvestri
, Carolina Reduzzi
, et al.
·
Cancers
·
12
PDF
Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma
2023
·
Marco Silvestri
, Trung Nghia Vu
, et al.
·
Cancer Medicine
·
11
PDF
Can we define breast cancer HER2 status by liquid biopsy?
2023
·
Serena Di Cosimo
, Cinzia De Marco
, et al.
·
International review of cytology
·
11
A gene expression-based classifier for HER2-low breast cancer
2024
·
Serena Di Cosimo
, Sara Pizzamiglio
, et al.
·
Scientific Reports
·
10
PDF
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO
2023
·
Serena Di Cosimo
, Chiara M. Ciniselli
, et al.
·
Frontiers in Oncology
·
10
PDF
CK+/CD45+ (dual-positive) circulating cells are associated with prognosis in patients with advanced breast cancer.
2022
·
Carolina Reduzzi
, Lorenzo Gerratana
, et al.
·
Journal of Clinical Oncology
·
10
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNA
2022
·
E. La Rocca
, M. C. De Santis
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
10
PDF
The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features
2021
·
Chiara Romani
, Davide Capoferri
, et al.
·
Cancers
·
10
PDF
Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancer
2024
·
Serena Di Cosimo
, Marco Silvestri
, et al.
·
Scientific Reports
·
8
PDF
Bimodal ECG and PCG Cardiovascular Disease Detection: Exploring the Potential and Modality Contribution
2025
·
Alessia Calzoni
, Mattia Savardi
, et al.
·
Journal of Medical Systems
·
7
PDF
Detecting gene copy number alterations by Oncomine Comprehensive genomic profiling in a comparative study on FFPE tumor samples
2025
·
Fabio Bozzi
, Elena Conca
, et al.
·
Scientific Reports
·
7
PDF
Show more works
View as search
Works count:
48
Citation count:
656
H-index:
13
I10-index:
22
Year
Topic
Type